BIBI , N.; MALIK , M. COMPARISON OF 550MG/DAY VERSES 1100 MG/DAY RIFAXIMIN IN SECONDARY PREVENTION OF BOTH COVERT AND OVERT HEPATIC ENCEPHALOPATHY. Pakistan Journal of Intensive Care Medicine, [S. l.], v. 5, n. 01, p. 71, 2025. DOI: 10.54112/pjicm.v5i01.71. Disponível em: https://www.pjicm.com/ojs/index.php/home/article/view/71. Acesso em: 24 aug. 2025.